GSK PLC (GSK)
34.39
-0.72
(-2.05%)
USD |
NYSE |
Nov 14, 16:00
33.65
-0.74
(-2.15%)
Pre-Market: 06:37
GSK Cash and Short Term Investments (Quarterly): 4.298B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.298B |
| June 30, 2024 | 3.773B |
| March 31, 2024 | 5.170B |
| December 31, 2023 | 6.359B |
| September 30, 2023 | 8.154B |
| June 30, 2023 | 8.204B |
| March 31, 2023 | 8.639B |
| December 31, 2022 | 9.291B |
| September 30, 2022 | 7.997B |
| June 30, 2022 | 7.923B |
| March 31, 2022 | 18.36B |
| December 31, 2021 | 5.581B |
| September 30, 2021 | 4.718B |
| June 30, 2021 | 4.930B |
| March 31, 2021 | 6.621B |
| December 31, 2020 | 8.409B |
| September 30, 2020 | 5.616B |
| June 30, 2020 | 10.16B |
| March 31, 2020 | 6.006B |
| December 31, 2019 | 6.013B |
| September 30, 2019 | 5.397B |
| June 30, 2019 | 5.331B |
| March 31, 2019 | 5.495B |
| December 31, 2018 | 5.022B |
| September 30, 2018 | 5.046B |
| Date | Value |
|---|---|
| June 30, 2018 | 5.396B |
| March 31, 2018 | 5.718B |
| December 31, 2017 | 5.285B |
| September 30, 2017 | 6.480B |
| June 30, 2017 | 5.296B |
| March 31, 2017 | 5.736B |
| December 31, 2016 | 6.125B |
| September 30, 2016 | 6.091B |
| June 30, 2016 | 6.291B |
| March 31, 2016 | 6.448B |
| December 31, 2015 | 8.748B |
| September 30, 2015 | 9.061B |
| June 30, 2015 | 11.97B |
| March 31, 2015 | 15.35B |
| December 31, 2014 | 6.859B |
| September 30, 2014 | 6.774B |
| June 30, 2014 | 5.496B |
| March 31, 2014 | 5.957B |
| December 31, 2013 | 9.234B |
| September 30, 2013 | 5.365B |
| June 30, 2013 | 4.443B |
| March 31, 2013 | 5.949B |
| December 31, 2012 | 6.892B |
| September 30, 2012 | 5.870B |
| June 30, 2012 | 11.78B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.773B
Minimum
Jun 2024
18.36B
Maximum
Mar 2022
7.311B
Average
6.490B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AstraZeneca PLC | 7.076B |
| Pfizer Inc | 9.952B |
| Autolus Therapeutics PLC | 705.94M |
| Moderna Inc | 6.867B |
| Biodexa Pharmaceuticals PLC | 6.394M |